Cargando…
Risk factor targeting for vaccine prioritization during the COVID-19 pandemic
A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk factor, such as age. We provide a more granular...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866501/ https://www.ncbi.nlm.nih.gov/pubmed/35197495 http://dx.doi.org/10.1038/s41598-022-06971-5 |
_version_ | 1784655853629997056 |
---|---|
author | Chapman, Lloyd A. C. Shukla, Poojan Rodríguez-Barraquer, Isabel Shete, Priya B. León, Tomás M. Bibbins-Domingo, Kirsten Rutherford, George W. Schechter, Robert Lo, Nathan C. |
author_facet | Chapman, Lloyd A. C. Shukla, Poojan Rodríguez-Barraquer, Isabel Shete, Priya B. León, Tomás M. Bibbins-Domingo, Kirsten Rutherford, George W. Schechter, Robert Lo, Nathan C. |
author_sort | Chapman, Lloyd A. C. |
collection | PubMed |
description | A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk factor, such as age. We provide a more granular approach with stratification by demographics, risk factors, and location. We use this approach to compare the impact of different COVID-19 vaccine prioritization strategies on COVID-19 cases, deaths and disability-adjusted life years (DALYs) over the first 6 months of vaccine rollout, using California as a case example. We estimate the proportion of cases, deaths and DALYs averted relative to no vaccination for strategies prioritizing vaccination by a single risk factor and by multiple risk factors (e.g. age, location). When targeting by a single risk factor, we find that age-based targeting averts the most deaths (62% for 5 million individuals vaccinated) and DALYs (38%) and targeting essential workers averts the least deaths (31%) and DALYs (24%) over the first 6 months of rollout. However, targeting by two or more risk factors simultaneously averts up to 40% more DALYs. Our findings highlight the potential value of multiple-risk-factor targeting of vaccination against COVID-19 and other infectious diseases, but must be balanced with feasibility for policy. |
format | Online Article Text |
id | pubmed-8866501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-88665012022-02-25 Risk factor targeting for vaccine prioritization during the COVID-19 pandemic Chapman, Lloyd A. C. Shukla, Poojan Rodríguez-Barraquer, Isabel Shete, Priya B. León, Tomás M. Bibbins-Domingo, Kirsten Rutherford, George W. Schechter, Robert Lo, Nathan C. Sci Rep Article A key public health question during any disease outbreak when limited vaccine is available is who should be prioritized for early vaccination. Most vaccine prioritization analyses only consider variation in risk of infection and death by a single risk factor, such as age. We provide a more granular approach with stratification by demographics, risk factors, and location. We use this approach to compare the impact of different COVID-19 vaccine prioritization strategies on COVID-19 cases, deaths and disability-adjusted life years (DALYs) over the first 6 months of vaccine rollout, using California as a case example. We estimate the proportion of cases, deaths and DALYs averted relative to no vaccination for strategies prioritizing vaccination by a single risk factor and by multiple risk factors (e.g. age, location). When targeting by a single risk factor, we find that age-based targeting averts the most deaths (62% for 5 million individuals vaccinated) and DALYs (38%) and targeting essential workers averts the least deaths (31%) and DALYs (24%) over the first 6 months of rollout. However, targeting by two or more risk factors simultaneously averts up to 40% more DALYs. Our findings highlight the potential value of multiple-risk-factor targeting of vaccination against COVID-19 and other infectious diseases, but must be balanced with feasibility for policy. Nature Publishing Group UK 2022-02-23 /pmc/articles/PMC8866501/ /pubmed/35197495 http://dx.doi.org/10.1038/s41598-022-06971-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Chapman, Lloyd A. C. Shukla, Poojan Rodríguez-Barraquer, Isabel Shete, Priya B. León, Tomás M. Bibbins-Domingo, Kirsten Rutherford, George W. Schechter, Robert Lo, Nathan C. Risk factor targeting for vaccine prioritization during the COVID-19 pandemic |
title | Risk factor targeting for vaccine prioritization during the COVID-19 pandemic |
title_full | Risk factor targeting for vaccine prioritization during the COVID-19 pandemic |
title_fullStr | Risk factor targeting for vaccine prioritization during the COVID-19 pandemic |
title_full_unstemmed | Risk factor targeting for vaccine prioritization during the COVID-19 pandemic |
title_short | Risk factor targeting for vaccine prioritization during the COVID-19 pandemic |
title_sort | risk factor targeting for vaccine prioritization during the covid-19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866501/ https://www.ncbi.nlm.nih.gov/pubmed/35197495 http://dx.doi.org/10.1038/s41598-022-06971-5 |
work_keys_str_mv | AT chapmanlloydac riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT shuklapoojan riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT rodriguezbarraquerisabel riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT shetepriyab riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT leontomasm riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT bibbinsdomingokirsten riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT rutherfordgeorgew riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT schechterrobert riskfactortargetingforvaccineprioritizationduringthecovid19pandemic AT lonathanc riskfactortargetingforvaccineprioritizationduringthecovid19pandemic |